BlackRock reports 8% stake in SI-BONE shares
BlackRock, Inc. filed Amendment No. 7 to a Schedule 13G reporting its passive ownership in SI-BONE, Inc. common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BlackRock, Inc. filed Amendment No. 7 to a Schedule 13G reporting its passive ownership in SI-BONE, Inc. common stock. As of 06/30/2026, BlackRock’s reporting business units beneficially owned 3,558,735 shares of SI-BONE common stock, representing 8.0% of the class. BlackRock had sole voting power over 3,490,613 shares and sole dispositive power over 3,558,735 shares, with no shared voting or dispositive power. Various underlying clients have rights to dividends or sale proceeds, but no single person has an interest in more than five percent of SI-BONE’s outstanding common shares.
Key Figures
Key Terms
beneficially owned financial
Sole Voting Power financial
Sole Dispositive Power financial
parent holding company financial
Power of Attorney regulatory
Schedule 13G regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Does any individual client of BlackRock hold over 5% of SI-BONE (SIBN)?
What type of filing did BlackRock submit for its SI-BONE (SIBN) stake?
AI-generated analysis. How Rhea-AI works. Not financial advice.